Texas Permanent School Fund Corp Has $7.44 Million Position in IQVIA Holdings Inc. (NYSE:IQV)

Texas Permanent School Fund Corp reduced its position in IQVIA Holdings Inc. (NYSE:IQVFree Report) by 2.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 37,829 shares of the medical research company’s stock after selling 786 shares during the period. Texas Permanent School Fund Corp’s holdings in IQVIA were worth $7,443,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of IQV. Norges Bank purchased a new stake in IQVIA in the fourth quarter worth approximately $408,232,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its stake in shares of IQVIA by 1,852.5% during the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 2,066,764 shares of the medical research company’s stock valued at $423,466,000 after purchasing an additional 1,960,914 shares during the period. Alliancebernstein L.P. boosted its stake in shares of IQVIA by 19.1% during the second quarter. Alliancebernstein L.P. now owns 5,942,761 shares of the medical research company’s stock valued at $1,335,754,000 after purchasing an additional 952,850 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of IQVIA by 127.7% during the second quarter. JPMorgan Chase & Co. now owns 1,638,576 shares of the medical research company’s stock valued at $368,303,000 after purchasing an additional 918,872 shares during the period. Finally, AMF Tjanstepension AB purchased a new stake in shares of IQVIA during the third quarter valued at approximately $148,096,000. Hedge funds and other institutional investors own 86.82% of the company’s stock.

Insiders Place Their Bets

In other IQVIA news, insider Kevin C. Knightly sold 13,117 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $214.03, for a total value of $2,807,431.51. Following the completion of the transaction, the insider now owns 7,347 shares in the company, valued at $1,572,478.41. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently weighed in on IQV shares. Barclays increased their price objective on IQVIA from $215.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. StockNews.com lowered IQVIA from a “buy” rating to a “hold” rating in a research note on Thursday. Robert W. Baird increased their price objective on IQVIA from $221.00 to $226.00 and gave the company a “neutral” rating in a research note on Thursday, January 18th. JPMorgan Chase & Co. decreased their target price on IQVIA from $262.00 to $239.00 and set an “overweight” rating for the company in a report on Monday, November 13th. Finally, Citigroup upped their target price on IQVIA from $190.00 to $225.00 and gave the company a “neutral” rating in a report on Monday, December 11th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, IQVIA has an average rating of “Moderate Buy” and a consensus price target of $244.31.

Check Out Our Latest Stock Report on IQVIA

IQVIA Price Performance

IQV opened at $218.20 on Friday. The stock has a fifty day simple moving average of $219.68 and a two-hundred day simple moving average of $211.31. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 2.12. The company has a market cap of $39.82 billion, a price-to-earnings ratio of 36.67, a price-to-earnings-growth ratio of 2.49 and a beta of 1.48. IQVIA Holdings Inc. has a 12-month low of $167.42 and a 12-month high of $234.92.

About IQVIA

(Free Report)

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Further Reading

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQVFree Report).

Institutional Ownership by Quarter for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.